feed,title,long_url,short_url
Benzinga,Compass Therapeutics' Combo Therapy Shows Around 38% Overall Response Rate In Pretreated Biliary Tract Cancer Patients,https://benzinga.com/general/biotech/23/01/30498108/compass-therapeutics-combo-therapy-shows-around-38-overall-response-rate-in-pretreated-biliary-tr,https://da.gd/BtKRH
